Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 3
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Aguirre-Acevedo, Daniel Camilo Jaimes-Barragán, Fabian Henao, Eliana Tirado, Victoria Muñoz, Claudia Reiman, Eric M. Tariot, Pierre N. Langbaum, Jessica B. and Lopera, Francisco 2016. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene. International Psychogeriatrics, Vol. 28, Issue. 03, p. 503.


    Laakkonen, Marja-Liisa Kautiainen, Hannu Hölttä, Eeva Savikko, Niina Tilvis, Reijo S. Strandberg, Timo E. and Pitkälä, Kaisu H. 2016. Effects of Self-Management Groups for People with Dementia and Their Spouses-Randomized Controlled Trial. Journal of the American Geriatrics Society, Vol. 64, Issue. 4, p. 752.


    Hongisto, Kristiina Väätäinen, Saku Martikainen, Janne Hallikainen, Ilona Välimäki, Tarja Hartikainen, Sirpa Suhonen, Jaana and Koivisto, Anne M. 2015. Self-Rated and Caregiver-Rated Quality of Life in Alzheimer Disease with a Focus on Evolving Patient Ability to Respond to Questionnaires: 5-Year Prospective ALSOVA Cohort Study. The American Journal of Geriatric Psychiatry, Vol. 23, Issue. 12, p. 1280.


    ×

Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study

  • Ilona Hallikainen (a1), Tuomo Hänninen (a2), Mikael Fraunberg (a3), Kristiina Hongisto (a1), Tarja Välimäki (a4) (a5), Asta Hiltunen (a6), Pertti Karppi (a7), Juhani Sivenius (a1) (a8), Hilkka Soininen (a1) (a2) and Anne M. Koivisto (a1) (a2)
  • DOI: http://dx.doi.org/10.1017/S1041610213000653
  • Published online: 16 May 2013
Abstract
ABSTRACT

Background: We studied the suitability of The Consortium to Establish a Registry for Alzheimer's Disease Neuropsychological Battery (CERAD-NB) total score for monitoring Alzheimer's disease (AD) progression in early-diagnosed medicated patients. We also investigated possible differences in progression between patients with very mild or mild baseline AD.

Methods: In this three-year follow-up of 115 ALSOVA study patients with clinical dementia ratings (CDR) of very mild (0.5) or mild (1) AD, we analyzed total CERAD-NB, Mini-Mental State Examination (MMSE), Neuropsychiatric Inventory (NPI), The Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, and Clinical Dementia Rating Sum of Boxes scores. Correlations were identified with efficacy parameters.

Results: Over three years, total CERAD-NB declined significantly in both groups. Annual change rates of total CERAD-NB were also significant. Total CERAD-NB revealed annual differences in cognition between study groups, while MMSE did not. Total CERAD-NB correlated well with other cognitive and global measures, but not with NPI. For almost two years, the CDR-0.5 group maintained a higher activities of daily living than the CDR-1 group exhibited at baseline. Furthermore, the CDR-0.5 group showed milder neuropsychiatric symptoms at the end of follow-up than the CDR-1 group showed at baseline.

Conclusions: The CERAD total score is a suitable and sensitive follow-up tool in longitudinal AD trials. Cognition progression rates did not significantly differ between study groups; however, patients with very mild AD at baseline had milder neuropsychiatric symptoms after long-term follow-up. This emphasizes the importance of early diagnosis and assessment of neuropsychiatric symptoms at the diagnostic visit and during follow-up.

Copyright
Corresponding author
Correspondence should be addressed to: Anne Maria Koivisto, MD, PhD, Neurology of Neuro Center, Kuopio University Hospital, P.O. Box 1777, FIN-70211 Kuopio, Finland. Phone: +358-40-738 9049, +358-44-717 5629; Fax: +358-17-172305. Email: anne.koivisto@kuh.fi.
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

A. C. Bozoki , H. An , E. S. Bozoki and R. J. Little (2009). The existence of cognitive plateaus in Alzheimer's disease. Alzheimer's and Dementia, 5, 470478.

M. J. Chandler et al. (2005). A total score for the CERAD neuropsychological battery. Neurology, 65, 102106.

F. Cortes et al. (2008). Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR study. Alzheimer's and Dementia, 4, 2229.

J. L. Cummings , M. Mega , K. Gray , S. Rosenberg-Thompson , D. A. Carusi and J. Gornbein (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 23082314.

J. L. Cummings , E. Schneider , P. N. Tariot and S. M. Graham (2006). Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology, 67, 5763.

H. H. Feldman , B. Van Baelen , S. M. Kavanagh and K. E. Torfs (2005). Cognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis. Alzheimer Disease and Associated Disorders, 19, 2936.

M. F. Folstein , S. E. Folstein and P. R. McHugh (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.

D. Galasko et al. (1997). An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's disease cooperative study. Alzheimer Disease and Associated Disorders, 11 (Suppl. 2), S3339.

I. Hallikainen et al. (2012). Cognitive and neuropsychiatric symptom differences in early stages of Alzheimer's disease: Kuopio ALSOVA study. Dementia and Geriatric Cognitive Disorders Extra, 2, 209218. doi:10.1159/000338231.

C. P. Hughes , L. Berg , W. L. Danziger , L. A. Coben and R. L. Martin (1982). A new clinical scale for the staging of dementia. The British Journal of Psychiatry, 140, 566572.

K. Karttunen et al. (2011). Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease. International Journal of Geriatric Psychiatry, 26, 473482. doi:10.1002/gps.2550. Epub 2010 Oct 29.

G. McKhann , D. Drachman , M. Folstein , R. Katzman , D. Price and E. M. Stadlan (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939944.

T. McLaughlin et al. (2010). Assessment of potential measures in models of progression in Alzheimer disease. Neurology, 75, 12561262.

J. C. Morris (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 24122414.

J. C. Morris et al. (1993). The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology, 43, 24572465.

H. C. Rossetti , C. Munro Cullum , L. S. Hynan and L. H. Lacritz (2010). The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease. Alzheimer Disease and Associated Disorders, 24, 138142.

S. Salloway et al. (2009). A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology, 73, 20612070.

E. H. Seo et al. (2010). Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies. The American Journal of Geriatric Psychiatry, 18, 801809.

L. Serra et al. (2010). Relationship between cognitive impairment and behavioural disturbances in Alzheimer's disease patients. Behavioural Neurology, 23, 123130.

J. Stein et al. (2012). The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German study on ageing, cognition, and dementia in primary care patients (AgeCoDe). The American Journal of Geriatric Psychiatry, 20, 8497.

M. Steinberg et al. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. International Journal of Geriatric Psychiatry, 23, 170177.

R. E. Tractenberg , M. F. Weiner , J. L. Cummings , M. B. Patterson and L. J. Thal (2005). Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach. The Journal of Neuropsychiatry and Clinical Neurosciences, 17, 5160.

T. H. Välimäki , K. M. Vehviläinen-Julkunen , A. M. Pietilä and T. A. Pirttilä (2009). Caregiver depression is associated with a low sense of coherence and health-related quality of life. Aging and Mental Health, 13, 799807.

K. A. Welsh et al. (1994). The consortium to establish a registry for Alzheimer's disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology, 44, 609614.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: